BICB (BioCube) Revenue: $0.00 Mil (TTM As of Jul. 2013)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BioCube Revenue?

BioCube BICB -99.00% Revenue is $0.00 Mil as of Jul. 2013.

BioCube's revenue for the three months ended in Jul. 2013 was $0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Jul. 2013 was $0.00 Mil. BioCube's Revenue per Share for the three months ended in Jul. 2013 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jul. 2013 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


BioCube  (OTCPK:BICB) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


BioCube Revenue Related Terms


BioCube Revenue Historical Data

* Premium members only.

The historical data trend for BioCube's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCube Revenue Chart

BioCube Annual Data
Trend Jun06 Jun07 Jan08 Jan09 Jan11 Jan12 Jan13
Revenue
Get a 7-Day Free Trial 12.31 44.55 0.00 0.00 0.00

BioCube Quarterly Data
Apr08 Jul08 Oct08 Jan09 Apr09 Oct09 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BICB vs MBVXQ, GWSN, CTBOD: Revenue Comparison

For the Shell Companies subindustry, BioCube's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioCube Revenue vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, BioCube's Revenue distribution charts can be found below:

* The bar in red indicates where BioCube's Revenue falls into.



BioCube Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jul. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $0.00 Mil mean?
BioCube (BICB) has a Revenue of $0.00 Mil as of Jul. 2013. Revenue is the total amount a company generates as sales through its operations. View historical data on BioCube and its competitors.
Is BioCube's Revenue too high?
BioCube's current Revenue is $0.00 Mil.
How does BioCube's Revenue compare to MBVXQ and GWSN?
BioCube's Revenue of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Diversified Financial Services company?
A good Revenue depends on the Diversified Financial Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on BioCube and its competitors. BioCube's current Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioCube stock overvalued right now?
BioCube (BICB) has a current Revenue of $0.00 Mil. The current Revenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For BioCube (BICB), the current Revenue is $0.00 Mil as of Jul. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioCube Business Description

Address 3060 West 3680 South, Suite 92, West Valley, UT, USA, 84119
BioCube Inc is a shell company.